Drug shortage
Dextrose Monohydrate 10% Injection · Fresenius Kabi USA, LLC
FDA drug shortage · Current · updated Apr 1, 2025
Key facts
| Generic name | Dextrose Monohydrate 10% Injection |
|---|---|
| Proprietary name | Dextrose 10% In Plastic Container |
| Company | Fresenius Kabi USA, LLC |
| Presentation | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) |
| Dosage form | Injection |
| Strength | 100 mg/1 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Other Pediatric |
| Package NDCs | 63323-824-76 |
| First posted | Mar 1, 2022 |
| Last updated | Apr 1, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: